AGENUS INC Payments of Stock Issuance Costs
AGENUS INC (AGEN) reported Payments of Stock Issuance Costs of $0 for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2014-03-07
- AGENUS INC payments of stock issuance costs for the quarter ending 2012-06-30 was $140.00K.
- AGENUS INC payments of stock issuance costs for the quarter ending 2012-03-31 was $87.00K.
- AGENUS INC payments of stock issuance costs for fiscal 2011 was $38.00M.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2012-09-30 | $0.00 10-Q · filed 2012-11-07 | |||
| 2012-06-30 | $140.00K 10-Q · filed 2012-08-08 | $227.00K derived: sum of 2 quarters · filed 2012-08-08 | ||
| 2012-03-31 | $87.00K 10-Q · filed 2012-08-08 | |||
| 2011-12-31 | $38.00M 10-K · filed 2014-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |